← Back to Screener
InfuSystem Holdings, Inc. (INFU)
Price$10.79
Favorite Metrics
Price vs S&P 500 (26W)5.88%
Price vs S&P 500 (4W)6.90%
Market Capitalization$213.43M
P/E Ratio (Annual)32.21x
All Metrics
P/CF (Annual)8.74x
Book Value / Share (Quarterly)$2.84
P/TBV (Annual)3.62x
Revenue Growth (3Y)9.28%
Cash Flow / Share (Quarterly)$0.78
Price vs S&P 500 (YTD)13.81%
Gross Margin (TTM)55.98%
Net Profit Margin (TTM)4.62%
EPS (TTM)$0.32
10-Day Avg Trading Volume0.09M
EPS Excl Extra (TTM)$0.32
Revenue Growth (5Y)8.05%
EPS (Annual)$0.31
ROI (Annual)8.61%
Gross Margin (Annual)55.98%
Net Profit Margin (5Y Avg)1.69%
Cash / Share (Quarterly)$0.16
P/E Basic Excl Extra (TTM)32.21x
Revenue Growth QoQ (YoY)7.04%
EPS Growth (5Y)-17.01%
P/E Normalized (Annual)32.21x
ROA (Last FY)6.59%
Revenue Growth TTM (YoY)6.36%
EBITD / Share (TTM)$0.67
ROE (5Y Avg)4.06%
Operating Margin (TTM)8.31%
Cash Flow / Share (Annual)$0.78
P/B Ratio3.72x
P/B Ratio (Quarterly)3.18x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)1.60x
Net Interest Coverage (TTM)9.18x
ROA (TTM)6.55%
EPS Growth QoQ (YoY)126.74%
EV / EBITDA (TTM)16.37x
EPS Incl Extra (Annual)$0.31
Current Ratio (Annual)1.80x
Quick Ratio (Quarterly)1.53x
3-Month Avg Trading Volume0.12M
52-Week Price Return112.45%
EV / Free Cash Flow (Annual)14.62x
P/E Incl Extra (TTM)32.21x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$2.50
P/S Ratio (Annual)1.49x
Asset Turnover (Annual)1.43x
52-Week High$11.04
Operating Margin (5Y Avg)4.18%
EPS Excl Extra (Annual)$0.31
CapEx CAGR (5Y)-12.48%
Tangible BV CAGR (5Y)11.28%
26-Week Price Return14.63%
Quick Ratio (Annual)1.53x
13-Week Price Return21.33%
Total Debt / Equity (Annual)0.34x
Current Ratio (Quarterly)1.80x
Enterprise Value$229.871
Revenue / Share Growth (5Y)8.68%
Asset Turnover (TTM)1.42x
Book Value / Share Growth (5Y)7.16%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)10.59x
Pretax Margin (Annual)7.41%
Cash / Share (Annual)$0.16
3-Month Return Std Dev50.05%
Gross Margin (5Y Avg)54.82%
Net Income / Employee (TTM)$0
EBITDA CAGR (5Y)0.23%
EBITDA Interim CAGR (5Y)13.30%
ROE (Last FY)11.56%
Net Interest Coverage (Annual)9.18x
EPS Basic Excl Extra (Annual)$0.31
P/FCF (TTM)12.30x
Receivables Turnover (TTM)6.33x
EV / Free Cash Flow (TTM)14.62x
Total Debt / Equity (Quarterly)0.34x
EPS Incl Extra (TTM)$0.32
Receivables Turnover (Annual)6.25x
ROI (TTM)8.33%
P/S Ratio (TTM)1.49x
Pretax Margin (5Y Avg)2.80%
Revenue / Share (Annual)$6.80
Tangible BV / Share (Annual)$2.50
Forward P/E25.94x
Free OCF CAGR (5Y)36.11%
Price vs S&P 500 (52W)77.35%
P/E Ratio (TTM)32.21x
EPS Growth TTM (YoY)195.14%
Year-to-Date Return17.95%
5-Day Price Return8.74%
EPS Normalized (Annual)$0.31
ROA (5Y Avg)2.24%
Net Profit Margin (Annual)4.62%
Month-to-Date Return14.63%
Cash Flow / Share (TTM)$0.61
EBITD / Share (Annual)$0.67
EPS Growth (3Y)632.25%
Operating Margin (Annual)8.31%
LT Debt / Equity (Annual)0.34x
P/CF (TTM)8.74x
ROI (5Y Avg)2.87%
P/E Excl Extra (TTM)32.21x
LT Debt / Equity (Quarterly)0.34x
EPS Basic Excl Extra (TTM)$0.32
P/TBV (Quarterly)3.62x
P/B Ratio (Annual)3.18x
Inventory Turnover (TTM)10.59x
Pretax Margin (TTM)7.41%
Book Value / Share (Annual)$2.84
Price vs S&P 500 (13W)18.47%
Net Margin Growth (5Y)-23.64%
Beta1.56x
P/FCF (Annual)13.58x
Revenue / Share (TTM)$6.87
ROE (TTM)11.91%
52-Week Low$4.66
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.18
4.18
4.18
4.18
Industry Peers — Surgical & Medical Instruments(108)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
INFUInfuSystem Holdings, Inc. | 1.49x | 8.05% | 55.98% | 8.31% | $10.79 |
SYKStryker Corporation | 5.17x | 11.84% | 64.57% | 19.43% | $338.34 |
BSXBoston Scientific Corp. | 4.58x | 15.16% | 69.01% | 18.00% | $60.99 |
MMM3M Company | 3.21x | -4.97% | 39.92% | 18.55% | $151.40 |
MDLNMedline Inc. Class A common stock | 2.20x | — | 26.44% | 7.78% | $48.26 |
BDXBecton, Dickinson and Co. | 2.06x | 6.32% | 46.42% | 12.15% | $158.64 |
RMDResMed Inc. | 6.07x | 11.72% | 60.85% | 33.70% | $226.14 |
DXCMDexCom, Inc. | 5.33x | 19.33% | 62.09% | 19.56% | $64.62 |
WSTWest Pharmaceutical Services, Inc. | 6.29x | 7.44% | 35.91% | 19.03% | $278.00 |
PODDInsulet Corporation | 5.19x | 24.53% | 71.63% | 12.92% | $200.87 |
PENPenumbra, Inc. | 9.24x | 20.16% | 67.14% | 13.48% | $329.71 |
About
InfuSystems Holdings Inc is a healthcare services provider offering durable medical equipment (DME), consumables, and related support services to patients and healthcare providers. The company operates two segments: Patient Services (primary revenue driver) providing DME supply, order fulfillment, 24/7 clinical support, and insurance billing services; and Device Solutions offering equipment rentals and sales with biomedical support. The integrated platform manages the complete DME care cycle, combining supply, logistics, and clinical support services.